Both in Pharmaceuticals
Summit Therapeutics vs TG Therapeutics
Over the past year SMMT returned −7.5% and TGTX returned +82.3%; their daily moves had a correlation of 0.23.
SMMT −7.5% TGTX +82.3%Growth of $1, one year, split-adjusted
| Metric | SMMT | TGTX |
|---|---|---|
| Price | $16.17 | $61.63 |
| Market cap | $12.90B | $9.43B |
| Today | +2.34% | +1.45% |
| 1 month | −6.6% | +18.1% |
| 6 months | −9.4% | +46.8% |
| Year to date | −7.5% | +106.7% |
| 1 year | −11.3% | +82.9% |
| Revenue growth (YoY) | — | +70.3% |
| Gross margin | — | 82.9% |
| Net margin | — | 3.2% |
| P/E (TTM) | — | 21.4× |
| Price / sales | — | 11.8× |
| Net cash | $690.7M | -$193.1M |
| Dividend yield | — | — |
| Volatility (60d) | 70.7% | 36.8% |
| Short % of float | 29.5% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).